Active Ingredient History
Growth hormone (GH) or somatotropin, also known as human growth hormone in its human form, is a peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals. It is thus important in human development. GH also stimulates production of IGF-1 and increases the concentration of glucose and free fatty acids. It is a type of mitogen which is specific only to the receptors on certain types of cells. GH is a 191-amino acid, single-chain polypeptide that is synthesized, stored and secreted by somatotropic cells within the lateral wings of the anterior pituitary gland. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
| Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
|---|
Aging (Phase 2)
Airway Extubation (Phase 2)
Amyotrophic Lateral Sclerosis (Phase 2)
Anorexia Nervosa (Phase 2/Phase 3)
Anterior Cruciate Ligament Injuries (Phase 2)
Arthritis, Juvenile (Phase 3)
Ataxia Telangiectasia (Phase 4)
Atherosclerosis (Phase 3)
Body Image (Phase 4)
Body Weight Changes (Phase 1/Phase 2)
Bone Diseases, Metabolic (Phase 2)
Brain Concussion (Phase 3)
Brain Injuries (Phase 4)
Brain Injuries, Traumatic (Phase 4)
Burns (Phase 2/Phase 3)
Cardiovascular Diseases (Phase 4)
Chromosome Aberrations (Phase 3)
Cognition (Phase 4)
Cognition Disorders (Phase 4)
Cognitive Dysfunction (Phase 3)
Crohn Disease (Phase 2/Phase 3)
Cystic Fibrosis (Phase 3)
Cystinosis (Phase 1/Phase 2)
Deficiency Diseases (Phase 1)
Developmental Disabilities (Phase 2)
Diabetes Mellitus (Phase 3)
Diabetes Mellitus, Type 1 (Phase 1)
Drugs, Investigational (Phase 2)
Dwarfism (Phase 4)
Endocrine System Diseases (Phase 3)
Exercise (Phase 4)
Failure to Thrive (Phase 3)
Familial Hypophosphatemic Rickets (Phase 1/Phase 2)
Fatigue (Phase 3)
Feeding and Eating Disorders (Phase 2)
Fertilization in Vitro (Phase 2)
Fetal Growth Retardation (Phase 3)
Fibromyalgia (Phase 3)
Fibrosis (Phase 2/Phase 3)
Fractures, Bone (Phase 2)
Frailty (Phase 2)
Genetic Diseases, Inborn (Phase 4)
Gestational Age (Phase 3)
Glucose Intolerance (Phase 4)
Gonadal Dysgenesis (Phase 2)
Growth and Development (Phase 4)
Growth Disorders (Phase 3)
Growth Hormone (Phase 4)
Healthy Volunteers (Phase 4)
Heart Diseases (Phase 3)
Heart Failure (Phase 3)
Heart Failure, Systolic (Phase 3)
Hematopoietic Stem Cell Transplantation (Phase 1)
HIV (Phase 3)
HIV-Associated Lipodystrophy Syndrome (Phase 1/Phase 2)
HIV Wasting Syndrome (Phase 3)
Hormones (Phase 3)
Human Growth Hormone (Phase 3)
Hypogonadism (Phase 2)
Hypoparathyroidism (Phase 2/Phase 3)
Hypopituitarism (Phase 4)
Hypothyroidism (Phase 4)
Immunosenescence (Phase 2)
Infant, Premature, Diseases (Phase 2)
Infant, Small for Gestational Age (Phase 4)
Infant, Very Low Birth Weight (Phase 2)
Infertility (Phase 4)
Infertility, Female (Phase 4)
Insulin (Phase 2)
Insulin Resistance (Phase 1/Phase 2)
Kidney Failure, Chronic (Phase 4)
Leukemia, Myeloid, Acute (Phase 2/Phase 3)
Lipodystrophy (Phase 4)
Metabolic Syndrome (Phase 4)
Mucopolysaccharidosis I (Phase 2/Phase 3)
Mucopolysaccharidosis II (Phase 2/Phase 3)
Mucopolysaccharidosis VI (Phase 2/Phase 3)
Multiple Myeloma (Phase 2/Phase 3)
Muscle Weakness (Phase 2)
Muscular Atrophy, Spinal (Phase 2)
Muscular Diseases (Phase 1/Phase 2)
Muscular Dystrophy, Facioscapulohumeral (Phase 1)
Myelodysplastic Syndromes (Phase 2/Phase 3)
Myocardial Ischemia (Phase 2)
Non-alcoholic Fatty Liver Disease (Early Phase 1)
Noonan Syndrome (Phase 3)
Obesity (Phase 4)
Obesity, Abdominal (Phase 3)
Osteoarthritis, Knee (Early Phase 1)
Osteogenesis Imperfecta (Phase 3)
Osteopetrosis (Phase 2/Phase 3)
Osteoporosis (Phase 3)
Ovarian Diseases (Phase 4)
Pituitary Diseases (Phase 3)
Pituitary Neoplasms (Phase 4)
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2/Phase 3)
Pseudohypoparathyroidism (Phase 2/Phase 3)
Puberty, Delayed (Phase 2/Phase 3)
Renal Dialysis (Phase 3)
Rickets, Hypophosphatemic (Phase 1)
Sarcopenia (Phase 2)
Septo-Optic Dysplasia (Phase 4)
Spinal Cord Injuries (Phase 3)
Tendinopathy (Phase 2)
Uterine Diseases (Phase 3)
Ventilators, Mechanical (Phase 2)
| Trial | Phase | Start Date | Organizations | Indications |
|---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue
